[HTML][HTML] Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair

M Lech, HJ Anders - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2013 - Elsevier
Certain macrophage phenotypes contribute to tissue fibrosis, but why? Tissues host resident
mononuclear phagocytes for their support to maintain homeostasis. Upon injury the …

Mechanism of endothelial dysfunction in chronic kidney disease

J Malyszko - Clinica chimica acta, 2010 - Elsevier
Endothelium is the largest organ in the body strategically located between the wall of blood
vessels and the blood stream. The human body contains approximately 1013 endothelial …

Nitric oxide deficiency in chronic kidney disease

C Baylis - American Journal of Physiology-Renal …, 2008 - journals.physiology.org
The overall production of nitric oxide (NO) is decreased in chronic kidney disease (CKD)
which contributes to cardiovascular events and further progression of kidney damage. There …

Angiogenesis: where do we stand now?

M Simons - Circulation, 2005 - Am Heart Assoc
The role of preexisting collateral channels in the heart is far less well established. Early
studies failed to show the existence of coronary-to-coronary artery connection in normal …

Indoxyl sulfate, a uremic endotheliotoxin

G Lano, S Burtey, M Sallée - Toxins, 2020 - mdpi.com
Chronic kidney disease (CKD) is associated with a high prevalence of cardiovascular
diseases. During CKD, the uremic toxin indoxyl sulfate (IS)—derived from tryptophan …

A bench to bedside view of uremic toxins

R Vanholder, U Baurmeister, P Brunet… - Journal of the …, 2008 - journals.lww.com
Reviewing the current picture of uremic toxicity reveals its complexity. Focusing on
cardiovascular damage as a model of uremic effects resulting in substantial morbidity and …

Arginine, arginine analogs and nitric oxide production in chronic kidney disease

C Baylis - Nature Clinical Practice Nephrology, 2006 - nature.com
Nitric oxide (NO) production is reduced in renal disease, partially due to decreased
endothelial NO production. Evidence indicates that NO deficiency contributes to …

Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists

FH Bahlmann, K de Groot, O Mueller, B Hertel… - …, 2005 - Am Heart Assoc
The number of circulating endothelial progenitor cells (EPCs) correlates with endothelial
dysfunction and cardiovascular risk in humans. We explored whether angiotensin II receptor …

Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?

N Werner, G Nickenig - Arteriosclerosis, thrombosis, and vascular …, 2006 - Am Heart Assoc
The ideal way to prevent and cure atherosclerosis and the subsequent end organ damage is
to restore and rejuvenate the dysfunctional vasculature and the damaged organs. Various …

[HTML][HTML] Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients

S Liabeuf, A Lenglet, L Desjardins, N Neirynck… - Kidney international, 2012 - Elsevier
Since beta-2 microglobulin (B2M) is a surrogate marker for middle molecular weight uremic
toxins and the major protein component in dialysis-related amyloidosis, it has been …